A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
These Stocks Are Moving the Most Today: GM, Disney, Alphabet, Western Digital, SoFi, Apple, and More
Forza Motorsport Game Pass Release Date
Apple iPhone 15 vs. Google Pixel 7: Android and iOS Do Battle
Apple AirPods (3rd Gen) are on sale for under $140 this Prime Day
Save 20% on a wall outlet expansion with a stylish design
Alibaba, Tencent’s $66 Billion Party Starts to Fade
F1 23 Driver Ratings Might Surprise You
Upgrade your smart home setup with Amazon Echo devices on sale for up to 42% off